Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
“Approximately 250 tons of natural pozzolan will be extracted and processed at no cost to Sunrise.”
At least it looks like we can actually give something away! Now we just need to convince someone to part with some $$ for it.
It doesn’t matter if it’s 5 or 55 after this length of time if our offering was of interest we should have a least one deal signed and sealed!
I hope I am wrong but so far my confidence is low of ever seeing a return on this one!
https://pharmaphorum.com/podcast/understanding-the-tumour-micro-environment/
Listen to our #CMO Dr. Marie-Louise Fjällskog on the @pharmaphorum #podcast with @JonahComstock where she discusses the promise of #immunotherapy to manage difficult-to-treat cancers.
Patience is all well and good, but in Oct 20 we were advised we were looking at Spring 21 for first commercial production. Two years later we have a wall of silence and a product either nobody wants to buy, or nobody at the company knows how to sell!
He still sounds pretty confident about 11 days ago…https://youtu.be/mhxg-PQCi5g
We are funded until Q3 so some sort of raise was to be expected. I wonder if we will look to do a placing Stateside this time round?
Markku may play the game very well but he least he isn’t shy about having skin in the game, he bought another 25k shares 2 months ago…hardly the actions of someone that might be concerned about the way things are going.
“These amazing results have been based on just the patients they have been able to access , not select , as you would if the therapy was on the market .”
Also worth remembering many if not all of these patients will have been last line, having already had a number of treatments not work for them.
Todays RNS is eye catching!
“The strongest survival benefit was seen in checkpoint refractory melanoma and cholangiocarcinoma where 12 - month survival was 100% among patients who benefited from bexmarilimab treatment and 0% for patients who did not benefit from treatment”
Maybe that couple of years estimate was based on the last “potential offtake discussions”. I hope PC has the sense to put a time limit on this time, though probably not if the last 18 months is anything to go by!
It looks good to me, a nice step in the right direction but probably not the news that will light the blue touch paper.
Being able to predict with more accuracy who Bex will work on can only be a great thing, especially as we look to design a P3 trial.
This was from the 24th May 2021, at least PC won’t have to update it for this years report…
“Whilst we have been frustrated with a slower than anticipated progress on our flagship CS Project, due in no small part to delays in customer testing, our large mine-permitted deposits of natural pozzolan and perlite provide a valuable base on which to build and we believe that there is much to look forward to in the coming months, both for the CS Project and for the Company in general.”
Can anyone confirm what we had to look forward to…I seem to have missed those RNS’s.